Reasons for discontinuation of subcutaneous interferon β-1a three times a week among patients with multiple sclerosis: a real-world cohort study

BACKGROUND: Continuation of interferon (IFN) β-based therapies is important for maximum treatment effectiveness in patients with multiple sclerosis (MS); however, few real-world data are available on discontinuation from IFN β. The aim of this cohort analysis was to estimate real-world discontinuati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabidó-Espin, Meritxell, Munschauer, Rick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364602/
https://www.ncbi.nlm.nih.gov/pubmed/28335743
http://dx.doi.org/10.1186/s12883-017-0831-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364602/
https://www.ncbi.nlm.nih.gov/pubmed/28335743
http://dx.doi.org/10.1186/s12883-017-0831-4

Ejemplares similares